Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 23/04/18

Trade details

Type
Insider sale
Amount
$1,056,745.08
Shares · price
4,581 sh · $230.68 a share
Held after
509 sh
Trade date
23/04/17
Filed
23/04/18
Days to filing
1 days

Sold 90.0% of holdings

Share of holding sold
90.0%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/18~23/05/17

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $775.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $537.5K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $501.3K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $477.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $446.5K

    Filed 10/02

Martine A. Rothblatt, Chairman — sold $1.1M of United Therapeutics UTHR · 90.0% of holdings | Whalegun